Skip to main content

Interpretation of concurrent positive skin tests to prophylactic antibiotics and rocuronium

To the Editor,

We read with great interest the article by Yasuda et al. on concurrent positive skin tests to prophylactic antibiotics and rocuronium in two patients [1]. The authors hypothesized the possible synergistic effect of antibiotics and neuromuscular blocking agents (NMBAs) on anaphylactic reactions. As evidence to support their hypothesis, they quoted a previous study that showed that patients with positive skin tests to antibiotics were more likely to have positive skin tests to NMBAs [2]. However, we believe that the evidence to prove their hypothesis is insufficient for the reasons described below.

First, since the authors did not indicate the concentration of drugs being tested when the skin test was positive, the possibility of false-positive skin test results cannot be ruled out. In general, false positives should be kept in mind when skin tests are positive, especially when they are positive for two or more drugs. NMBAs, in particular, are well known as drugs that are prone to producing false-positive results. Adherence to the maximum concentrations of drugs recommended in the guidelines is crucial to avoid false-positive results in skin testing [3]. Further, lack of information on both the method of determining the positive skin test and photographs of the skin test results is another reason why we suspect there could have been false-positive results in these two cases.

Next, it is possible that case 2 might not even have developed anaphylaxis, since other possible causes can explain the observed decrease in blood pressure and percutaneous oxygen saturation (SpO2): hypotension might have occurred secondary to the effect of epidural anesthesia and anesthesia-inducing drugs. Since a decrease in SpO2 occurs after pneumoperitoneum, the cause for decrease in SpO2 could likely have been atelectasis due to elevation of the diaphragm. Additionally, no increase in serum tryptase was observed. Applying the clinical score of perioperative anaphylaxis to case 2 gives a total of 6 points: 6 points for severe hypotension, 2 points for a poor response to the standard dose of sympathomimetics, 3 points for the onset of cardiovascular features within 15 min of a possible intravenous trigger (including our estimates), − 1 point for neuraxial regional anesthesia, and − 4 points for absence of tryptase elevation [4]. A score of less than 8 is defined as “unlikely to be an immediate hypersensitivity reaction”, suggesting that case 2 was not anaphylaxis [4]. Further, the cut-off value for serum tryptase mentioned by the authors (5.7 ng/ml) is different from the cut-off value that is generally used (11.4 ng/ml). Alternatively, basal tryptase × 1.2 + 2 ng/ml is the recommended gold standard threshold in evaluating mast cell activation [5].

In summary, the authors’ hypothesis is promising and worth investigating. However, their claim that both cases represented anaphylaxis cases with positive skin tests to muscle relaxants and antibiotics might not be correct for the reasons given above. We recommend the combined use of in vitro tests with high specificity, for example, the basophil activation test, when skin tests show ambiguous results, including positivity for multiple drugs.

Availability of data and materials

Not applicable.



Neuromuscular blocking agent

SpO2 :

Percutaneous oxygen saturation


  1. 1.

    Yasuda M, Moriwaki K, Tsutsumi YM. Concurrent positive skin tests to prophylactic antibiotics and rocuronium in two patients with life-threatening anaphylaxis after induction of anesthesia. JA Clin Rep. 2021;7(1):37.

    Article  Google Scholar 

  2. 2.

    Hagau N, Gherman N, Cocis M, Petrisor C. Antibiotic-induced immediate type hypersensitivity is a risk factor for positive allergy skin tests for neuromuscular blocking agents. Allergol Int. 2016;65(1):52–5 https://doi. org/10.1016/j.alit.2015.07.007.10.

    CAS  Article  Google Scholar 

  3. 3.

    Mertes PM, Malinovsky JM, Jouffroy L, the Working Group of the SFAR and SFA and Aberer W, Terreehorst I, Brockow K, et al. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J Investig Allergol Clin Immunol. 2011;21(6):442–53.

    CAS  PubMed  Google Scholar 

  4. 4.

    Hopkins PM, Cooke PJ, Clarke RC, Guttormsen AB, Platt PR, Dewachter P, et al. Consensus clinical scoring for suspected perioperative immediate hypersensitivity reactions. Br J Anaesth. 2019;123(1):e29–37.

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Valent P, Bonadonna P, Hartmann K, Broesby-Olsen S, Brockow K, Butterfield JH, et al. Why the 20% + 2 tryptase formula is a diagnostic gold standard for severe systemic mast cell activation and mast cell activation syndrome. Int Arch Allergy Immunol. 2019;180(1):44–51.

    CAS  Article  Google Scholar 

Download references


The authors thank FORTE Science Communications (Tokyo, Japan) for English language editing.


This study was supported by JSPS KAKENHI grant number 20K17829.

Author information




All authors contributed to writing the manuscript and approved the final manuscript.

Corresponding author

Correspondence to Tomonori Takazawa.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nagumo, K., Takazawa, T. & Saito, S. Interpretation of concurrent positive skin tests to prophylactic antibiotics and rocuronium. JA Clin Rep 7, 65 (2021).

Download citation